Is Rapport Therapeutics, Inc. Common Stock (RAPP) a Buy, Sell, or Hold?
Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP
$41.46 USD
$0.87 (2.14%)
- Volume
- 419.72K
- Average Volume
- 385.25K
- Market Capitalization
- $1.51B
- P/E Ratio
- -15.95
- Dividend Yield
- 0.00%
- Price Target
- $56.00
- Year High
- $43.76
- Year Low
- $13.43
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $27.08
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-26.0% DOWNSIDE
$56.00 Price Target
UPSIDE/DOWNSIDE HIGH
-37.2% DOWNSIDE
$66.00 Price Target High
UPSIDE/DOWNSIDE LOW
-3.6% DOWNSIDE
$43.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Raymond James | Tiago Fauth | $66 | $34.1199 | 2026-04-10 05:40 AM | 93.4% |
| BTIG | Kambiz Yazdi | $47 | $29.965 | 2026-03-09 09:49 AM | 56.8% |
| Wells Fargo | Benjamin Burnett | $43 | $26.61 | 2026-02-02 05:58 AM | 61.6% |
| H.C. Wainwright | Douglas Tsao | $40 | $30.16 | 2025-12-09 06:09 AM | 32.6% |
| Truist Financial | Joon Lee | $44 | $24.85 | 2025-09-16 06:11 AM | 77.1% |
| Jefferies | Andrew Tsai | $35 | $25.44 | 2024-07-02 12:51 AM | 37.6% |